GLOBEALERT
Sign in
HEALTH● ELEVATEDSep 1 · Sep 1, 2026, 5:28 AM

Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ

Seeking Alpha Tech · global

Novartis has halted trials for autoimmune CAR-T therapies after three patient deaths were reported. This action impacts the development of a new treatment type and raises concerns about patient safety in clinical trials.

Read at Seeking Alpha Tech Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Health

HEALTHBREAKING20m agoEbola kills over 5,300 in fastest-growing outbreak on recordEuroNews [en]HEALTH59m agoUS Approves Cheap Version Of HIV Prevention ShotChannels TVHEALTH1h agoUS approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending AidsThe Independent WorldHEALTH1h agoUS approves economic version of HIV preventive treatmentClarín